Meilen, Switzerland

Guy Lemaillet

USPTO Granted Patents = 1 


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guy Lemaillet: Innovator in Medicinal Chemistry

Introduction

Guy Lemaillet is a notable inventor based in Meilen, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on sulfonamide compounds. His research focuses on the development of new medicaments that can be used in the treatment of various diseases, including cancer.

Latest Patents

Guy Lemaillet holds a patent for "Sulfonamides and their use as a medicament." This invention relates to the use of a sulfonamide compound with a specific formula, which includes various functional groups that enhance its medicinal properties. The patent outlines the potential applications of these compounds in treating cancer, showcasing Lemaillet's commitment to advancing medical science.

Career Highlights

Throughout his career, Lemaillet has been associated with The Genetics Company, Inc., where he has collaborated with other talented professionals in the field. His work has led to the development of innovative solutions that address critical health challenges. With a focus on research and development, Lemaillet continues to push the boundaries of what is possible in medicinal chemistry.

Collaborations

Guy Lemaillet has worked alongside esteemed colleagues such as Gabriel Garcia and Pierre Daram. These collaborations have fostered a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking research.

Conclusion

Guy Lemaillet's contributions to the field of medicinal chemistry are noteworthy, particularly his patent on sulfonamides for cancer treatment. His dedication to innovation and collaboration continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…